Explorer les evidences

106 cells_per_mm3CD4 count increased by a median of 106 cells/mm3 at 12 months.

CamerounVIH/sidaobservé 12 monthspublié 2005Antiviral TherapyOpenAlexdocument de 8 observationsDOI 10.1177/135965350501000208

6,1 %Seroprevalence to orthoebolaviruses in bats from Cameroon, the Democratic Republic of Congo, and Guinea ranged between 6.1% and 18.9% depending on cut-off calculations.

Cameroun · Guinéeorthoebolavirusespublié 2023VirusesOpenAlexdocument de 5 observationsDOI 10.3390/v15091927

7,4 %HIV seroprevalence in a general population of southern Cameroon is 7.4%.

CamerounVIH/sidapublié 2007Emerging infectious diseasesOpenAlexdocument de 7 observationsDOI 10.3201/eid1303.061069

85 %In Cameroon, 45 out of 53 participants with advanced HIV disease were critically unwell, representing 85%.

CamerounVIH avancéHAL · Unilimdocument de 205 observations

8,3 %Early cardiac autonomic neuropathy was found in 8.3% of the patients.

Camerounneuropathie périphériquepublié 2022Annales de cardiologie et d'angeiologieeurope_pmcdocument de 8 observations

83,1 odds_ratioPeople with type 2 diabetes had greater odds of taking at least one medicine (OR 83.1 [95% CI: 37.1–185.8]) compared with people without diabetes.

Cameroundiabète de type 2publié 2017BMC health services researcheurope_pmcdocument de 7 observationsDOI 10.1186/s12913-017-2197-0

52,8 %Diabetes defined as HbA1c ≥6.5% had a pooled sensitivity of 52.8% (95% CI 51.3–54.3%) compared with FPG ≥7.0 mmol/L for diagnosing previously undiagnosed participants.

Cameroundiabète (non précisé)publié 2015The lancet. Diabetes & endocrinologyeurope_pmcdocument de 5 observationsDOI 10.1016/s2213-8587(15)00129-1

66 088 individualsA total of 66,088 individuals with type 2 diabetes were recruited by 6099 physicians from 49 countries.

Cameroundiabète de type 2observé 2005-2017publié 2020Diabetologiaeurope_pmcdocument de 2 observations

36,4 %Deaths from lower respiratory infections among children younger than 5 years decreased by 36.4% between 2007 and 2017.

Camerounlower respiratory infectionsobservé 2007 to 2017publié 2018Lancet (London, England)europe_pmcdocument de 15 observations

1 specimensPhylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 1 was subtype H.

CamerounVIH/sidapublié 2000AIDS Research and Human RetrovirusesOpenAlexdocument de 7 observations

148 samples148 out of 424 HIV-positive samples were identified as non-A HIV-1 subtypes.

Camerounnon-A HIV-1 subtypespublié 1998PubMedOpenAlexdocument de 10 observations

9 %Nine percent of HIV sequences (29/321) were from participants reporting previous exposure to antiretrovirals.

CamerounVIH/sidaobservé 2015publié 2018The Journal of antimicrobial chemotherapyeurope_pmcdocument de 12 observationsDOI 10.1093/jac/dky221

13 %The prevalence of diabetes in urban communities in Africa is 1-13% or more among adults.

Cameroundiabète (non précisé)publié 2001Diabetes & metabolismeurope_pmcdocument de 4 observations

Erycristagallin significantly reduced the chronic inflammation and leukocyte infiltration induced by repeated application of TPA.

Camerounchronic inflammation and leukocyte infiltration induced by repeated application of TPApublié 2003European journal of pharmacologyeurope_pmcdocument de 5 observations

39,4 %The prevalence of spirometric restrictive ventilatory pattern in the diabetes group was 39.4%.

Cameroundiabète de type 2 · spirometric restrictive ventilatory patternobservé December 2018 to March 2019publié 2021Respiratory medicine and researcheurope_pmcdocument de 3 observations

0,544 beta_coefficientIn age, sex and body mass index adjusted models, increasing Log10LTL was associated with increasing total cholesterol (β = 0.544).

Camerouncardio-metabolic diseasespublié 2022Medicineeurope_pmcdocument de 12 observations

5,27 %The glycemic index for nkui sauce with foofoo corn was 5.27%.

Cameroundiabète (non précisé) · obésitépublié 2015Clinical diabetes and endocrinologyeurope_pmcdocument de 6 observations

4,1 %The age-standardized prevalence of diabetes increased from 4.1% to 8.9% in women in sub-Saharan African countries between 1980 and 2014.

Cameroundiabète (non précisé)observé 1980publié 2017International journal of epidemiologyeurope_pmcdocument de 11 observationsDOI 10.1093/ije/dyx078

10,8 odds_ratioThe summary odds ratio between non-autoimmune diabetes and SARS-CoV-2 infection risk was 10.8 (95% CI: 10.3–11.4) based on one study.

CamerounCOVID-19 · non-autoimmune diabetes mellituspublié 2021Scientific reportseurope_pmcdocument de 11 observationsDOI 10.1038/s41598-021-88598-6

50 %Circulating recombinant form CRF02_AG accounted for 50% of the studied HIV infections in Cameroonian blood donors.

CamerounVIH/sidapublié 2013Virology JournalOpenAlexdocument de 7 observationsDOI 10.1186/1743-422x-10-29

3 HbA1c_pointsImmediate non-surgical periodontal treatment induced a reduction of HbA1c levels by 3.0 ± 2.4 points from 9.7 ± 1.6% at baseline to 6.7 ± 2.0% 3 months after NSPT.

Cameroundiabète de type 2publié 2018BMC oral healtheurope_pmcdocument de 6 observations

51 %Diabetic hospitalization admissions were higher during the rainy season (51%, 1633/3232) than the dry season in Yaounde.

Cameroundiabète (non précisé)publié 2016BMC public healtheurope_pmcdocument de 12 observationsDOI 10.1186/s12889-016-3090-1

49 units/dayThe mean insulin dose was 49 ± 20 units/day upon arrival at camp.

Cameroundiabète de type 1publié 2016BMC endocrine disorderseurope_pmcdocument de 6 observations

97,1 %Specificity for the detection of moderate nonproliferative diabetic retinopathy using the smartphone-based retinal camera was 97.1%.

Camerounmoderate nonproliferative diabetic retinopathypublié 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument de 16 observations

3,5 unitsCapsaicin significantly reduced neuropathic pain in the intervention group after 6 weeks, with a mean pain intensity of 3.5±1.3 compared to 4.8±1.3 in the placebo group (p=0.018).

Cameroundiabetic peripheral neuropathypublié 2020The Efficacy of topical Capsaicin in the management of painful diabetic peripheral neuropaeurope_pmcdocument de 6 observationsDOI 10.21203/rs.3.rs-19190/v1